
Eton Pharmaceuticals, Inc.: shareholders and insiders
Price
$61.36
November 19, 2026Market cap $1.8B
What Ploutos Investor adds for Eton Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 30% since Nov 5, 2026, when the 10-Q these figures come from was filed ($47.15 then, $61.36 on Nov 19, 2026). The figures date from before that move.10-Q
- Most of the reported profit is a tax credit, not money earned from customers. We leave out the P/E and the earnings growth, which would not compare with a company that paid tax.
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Opaleye Management Inc.with 2 more personsShare of class8.54%
- EcoR1 Capital, LLCwith 2 more personsShare of class7.70%
- BlackRock, Inc.Share of class6.90%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Opaleye Management Inc.with 2 more persons | 8.54% | 2.44M | Nov 6, 2026 | 13G/A | |
| EcoR1 Capital, LLCwith 2 more persons | 7.70% | 1.98M | Feb 14, 2025 | 13G/A | |
| BlackRock, Inc. | 6.90% | 1.88M | Jul 28, 20262 filings since Jul 17, 2025 | 13G/A |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 26, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter+127%
- Citadel Advisors (Griffin)In the quarter-32%
- D.E. ShawIn the quarter-62%
- Renaissance TechnologiesIn the quarter-72%
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 102.2K | +127% | $5.3M | 0.01% |
| Citadel Advisors (Griffin) | 33.4K | -32% | $1.7M | 0.00% |
| D.E. Shaw | 70.9K | -62% | $3.7M | 0.00% |
| Renaissance Technologies | 14.5K | -72% | $700.0K | 0.00% |
| AQR Capital | 14.0K | $700.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 6.74% of its shares outstanding were held short, +6.0% since the report before.
- Shares held short
- 1.94M
- 6.74%
- Since the report before1.83M on Sep 30, 2026
- +6.0%
- 3.3
- 588.4K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 39%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 954.6K
- Nov 15, 2023: Shares held short 753.6K
- Nov 30, 2023: Shares held short 620.9K
- Dec 15, 2023: Shares held short 363.8K
- Dec 29, 2023: Shares held short 445.8K
- Jan 12, 2024: Shares held short 381.2K
- Jan 31, 2024: Shares held short 384.0K
- Feb 15, 2024: Shares held short 366.2K
- Feb 29, 2024: Shares held short 227.2K
- Mar 15, 2024: Shares held short 242.9K
- Mar 28, 2024: Shares held short 220.4K
- Apr 15, 2024: Shares held short 148.1K
- Apr 30, 2024: Shares held short 87.4K
- May 15, 2024: Shares held short 85.2K
- May 31, 2024: Shares held short 54.6K
- Jun 14, 2024: Shares held short 78.7K
- Jun 28, 2024: Shares held short 71.3K
- Jul 15, 2024: Shares held short 60.9K
- Jul 31, 2024: Shares held short 75.2K
- Aug 15, 2024: Shares held short 69.6K
- Aug 30, 2024: Shares held short 71.5K
- Sep 13, 2024: Shares held short 75.5K
- Sep 30, 2024: Shares held short 126.3K
- Oct 15, 2024: Shares held short 204.6K
- Oct 31, 2024: Shares held short 191.9K
- Nov 15, 2024: Shares held short 206.5K
- Nov 29, 2024: Shares held short 273.9K
- Dec 13, 2024: Shares held short 278.0K
- Dec 31, 2024: Shares held short 245.1K
- Jan 15, 2025: Shares held short 327.7K
- Jan 31, 2025: Shares held short 340.9K
- Feb 14, 2025: Shares held short 353.0K
- Feb 28, 2025: Shares held short 289.4K
- Mar 14, 2025: Shares held short 235.6K
- Mar 31, 2025: Shares held short 343.9K
- Apr 15, 2025: Shares held short 402.6K
- Apr 30, 2025: Shares held short 702.5K
- May 15, 2025: Shares held short 589.5K
- May 30, 2025: Shares held short 823.8K
- Jun 13, 2025: Shares held short 1.12M
- Jun 30, 2025: Shares held short 2.36M
- Jul 15, 2025: Shares held short 3.05M
- Jul 31, 2025: Shares held short 3.32M
- Aug 15, 2025: Shares held short 3.56M
- Aug 29, 2025: Shares held short 3.69M
- Sep 15, 2025: Shares held short 3.65M
- Sep 30, 2025: Shares held short 3.37M
- Oct 15, 2025: Shares held short 3.02M
- Oct 31, 2025: Shares held short 2.92M
- Nov 14, 2025: Shares held short 2.78M
- Nov 28, 2025: Shares held short 2.50M
- Dec 15, 2025: Shares held short 2.45M
- Dec 31, 2025: Shares held short 2.16M
- Jan 15, 2026: Shares held short 2.03M
- Jan 30, 2026: Shares held short 2.00M
- Feb 13, 2026: Shares held short 2.11M
- Feb 27, 2026: Shares held short 2.22M
- Mar 13, 2026: Shares held short 1.90M
- Mar 31, 2026: Shares held short 1.89M
- Apr 15, 2026: Shares held short 1.79M
- Apr 30, 2026: Shares held short 1.63M
- May 15, 2026: Shares held short 1.55M
- May 29, 2026: Shares held short 1.26M
- Jun 15, 2026: Shares held short 1.43M
- Jun 30, 2026: Shares held short 1.45M
- Jul 15, 2026: Shares held short 1.23M
- Jul 31, 2026: Shares held short 1.31M
- Aug 14, 2026: Shares held short 1.43M
- Aug 31, 2026: Shares held short 1.35M
- Sep 15, 2026: Shares held short 1.54M
- Sep 30, 2026: Shares held short 1.83M
- Oct 15, 2026: Shares held short 1.94M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading59.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 59.5% of the shares in the reported trades were short sales, against 65.7% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 59.5%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 65.7%
- Change
- -6.2 pts
- Short sales a dayon average, of 318.7K shares
- 189.6K
- More than atof 3,666 US-listed companies, same days
- 81%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 53.4%
- Oct 14, 2026: Short sales 66.3%
- Oct 15, 2026: Short sales 69.1%
- Oct 16, 2026: Short sales 59.4%
- Oct 19, 2026: Short sales 53.2%
- Oct 20, 2026: Short sales 66.1%
- Oct 21, 2026: Short sales 70.6%
- Oct 22, 2026: Short sales 76.3%
- Oct 23, 2026: Short sales 75.6%
- Oct 26, 2026: Short sales 78.8%
- Oct 27, 2026: Short sales 60.8%
- Oct 28, 2026: Short sales 71.7%
- Oct 29, 2026: Short sales 72%
- Oct 30, 2026: Short sales 50.7%
- Nov 2, 2026: Short sales 68.1%
- Nov 3, 2026: Short sales 64.7%
- Nov 4, 2026: Short sales 53.9%
- Nov 5, 2026: Short sales 44.5%
- Nov 6, 2026: Short sales 40.9%
- Nov 9, 2026: Short sales 67.8%
- Nov 10, 2026: Short sales 78.9%
- Nov 11, 2026: Short sales 69.5%
- Nov 12, 2026: Short sales 57.1%
- Nov 13, 2026: Short sales 53%
- Nov 16, 2026: Short sales 61.6%
- Nov 17, 2026: Short sales 56.9%
- Nov 18, 2026: Short sales 47%
- Nov 19, 2026: Short sales 51%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.21%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.06%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.05%
- IWMiShares Russell 2000 ETFWeight in the fund0.03%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- DFUSDimensional U.S. Equity Market ETFWeight in the fund0.00%
11 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 103
- Q4 2025: Managers 104
- Q1 2026: Managers 118
- Q2 2026: Managers 165
Institutional investors by quarter
The fund managers holding ETON, quarter by quarter, from Q4 2018 to Q2 2025, 27 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 165 managers held 21.14M shares, worth $765M. During the quarter 55 opened a position, 8 closed one, 55 added and 34 trimmed.
The largest holders, Q2 2026
- Opaleye ManagementIn the quarter
- Nantahala Capital ManagementIn the quarter+100%
- EcoR1 CapitalIn the quarter
- BlackRockIn the quarter+10%
- Vanguard Capital ManagementIn the quarter-1.8%
- Morgan StanleyIn the quarter+61%
- State StreetIn the quarter+32%
- Geode Capital ManagementIn the quarter+13%
- Oberweis Asset Management Inc/In the quarter+14%
- National Philanthropic TrustIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Opaleye Management | 2.86M | $104M | |
| Nantahala Capital Management | 2.35M | +100% | $85M |
| EcoR1 Capital | 2.17M | $79M | |
| BlackRock | 1.90M | +10% | $69M |
| Vanguard Capital Management | 976.6K | -1.8% | $35M |
| Morgan Stanley | 768.0K | +61% | $28M |
| State Street | 701.8K | +32% | $25M |
| Geode Capital Management | 652.3K | +13% | $24M |
| Oberweis Asset Management Inc/ | 501.6K | +14% | $18M |
| National Philanthropic Trust | 492.1K | $18M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Eton Pharmaceuticals's filings show?
Who buys and sells is one part of Eton Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold ETON?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Point72 (Cohen)'s, worth $5.3M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.